Pullan’s Pieces II – A Business Development View of the Central Nervous System Landscape
12 ArticlesBest Practices & Trends ×
Precision Medicine in Central Nervous System Drug Development
This webinar discusses lessons we can learn from the use of precision medicine in oncology, how has a recent clinical precision medicine application shown potential in the treatment of Alzheimer’s, what questions should you ask before you add a new biomarker to your clinical trial, the pros and cons of using biomarkers as surrogate endpoints.
From Founding to Exit: A Life Science Business Founder Perspective
Bispecifics in Oncology and Immuno Oncology
This webinar roundtable explores interesting technologies, the scientific issues, the clinical opportunities for developing multivalent biologics platforms, whether certain technologies, such as antibodies, their fragments, or non-antibody scaffolds, are superior to others, the pros and cons of such bispecifics for improving management of patients, and licensing and commercial strategies.
Best Practices for Fundraising and M&A Due Diligence
This webinar explores the importance of establishing early goals and objectives for the process, how to get the right people to ask the right questions in advance of the process, how to build credibility by defining goals and demonstrating they can be achieved, much more.
The Nuts & Bolts of Due Diligence in Biopharma Partnering
The Good, The Bad and The Ugly of IP Monetization
Practical Application of Artificial Intelligence in Drug Discovery and Development
Tips & Tricks to Get the Most Out of ShareVault
Pullan’s Pieces – A Business Development View of the Oncology Landscape
Must-Know Finance Concepts for Life Sciences Valuations
M&A in the $800B+ Global Packaging Industry